カテゴリ： 世界, 医療/バイオ, Market Monitor Global

体重管理薬のグローバル市場展望 2023年-2029年：カプセル型、フレーク型

■ 英語タイトル：Weight Control Medication Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14516）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14516
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：115
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[体重管理薬のグローバル市場展望 2023年-2029年：カプセル型、フレーク型]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の体重管理薬市場規模と予測を収録しています。・世界の体重管理薬市場：売上、2018年-2023年、2024年-2029年
・世界の体重管理薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の体重管理薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カプセル型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

体重管理薬のグローバル主要企業は、Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcareなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、体重管理薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の体重管理薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の体重管理薬市場：タイプ別市場シェア、2022年
・カプセル型、フレーク型

世界の体重管理薬市場：用途別、2018年-2023年、2024年-2029年
世界の体重管理薬市場：用途別市場シェア、2022年
・子供、成人

世界の体重管理薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の体重管理薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における体重管理薬のグローバル売上、2018年-2023年
・主要企業における体重管理薬のグローバル売上シェア、2022年
・主要企業における体重管理薬のグローバル販売量、2018年-2023年
・主要企業における体重管理薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcare

*************************************************************

・調査・分析レポートの概要
体重管理薬市場の定義
市場セグメント
世界の体重管理薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の体重管理薬市場規模
世界の体重管理薬市場規模：2022年 VS 2029年
世界の体重管理薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの体重管理薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の体重管理薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カプセル型、フレーク型
体重管理薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子供、成人
体重管理薬の用途別グローバル売上・予測

・地域別市場分析
地域別体重管理薬市場規模 2022年と2029年
地域別体重管理薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcare
...

This research report provides a comprehensive analysis of the Weight Control Medication market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Weight Control Medication market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Weight Control Medication, challenges faced by the industry, and potential opportunities for market players.
The global Weight Control Medication market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Weight Control Medication market presents opportunities for various stakeholders, including Child, Aldult. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Weight Control Medication market. Additionally, the growing consumer demand present avenues for market expansion.
The global Weight Control Medication market was valued at US$ 1277.1 million in 2022 and is projected to reach US$ 2626.7 million by 2029, at a CAGR of 10.9% during the forecast period.
Weight management medications are medications used to help people manage their weight, lose weight, or treat obesity. Developments and trends in these drugs are constantly changing to reflect scientific research, medical needs, and social trends. As genetics and gene sequencing technologies advance, a future trend may be to better match weight management drugs to an individual’s genotype and metabolotype to achieve better personalized treatment results. It is expected that more weight management drug combinations will emerge to take advantage of the complementary effects of different drugs to improve the effectiveness of weight management.
Key Features:
The research report on the Weight Control Medication market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Weight Control Medication market.
Market Overview: The report provides a comprehensive overview of the Weight Control Medication market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Capsule Type, Flaky Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Weight Control Medication market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Weight Control Medication market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Weight Control Medication market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Weight Control Medication market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Weight Control Medication market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Weight Control Medication market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Weight Control Medication, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Weight Control Medication market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Weight Control Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Capsule Type
Flaky Type
Market segment by Application
Child
Aldult
Global Weight Control Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Versanis
Rivus Pharmaceuticals
Spitfire Pharma
GSK
Altimmune
Currax Pharmaceuticals
Wanbang Pharmaceutical Technology
Highfine Biotech
Keyuan Pharmaceutical
BrightGene Bio-Medical Technology
Sinopep-Allsino Bio Pharmaceutical
Dezhan Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Weight Control Medication, market overview.
Chapter 2: Global Weight Control Medication market size in revenue.
Chapter 3: Detailed analysis of Weight Control Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Weight Control Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Weight Control Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Weight Control Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Weight Control Medication Overall Market Size
2.1 Global Weight Control Medication Market Size: 2022 VS 2029
2.2 Global Weight Control Medication Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Weight Control Medication Players in Global Market
3.2 Top Global Weight Control Medication Companies Ranked by Revenue
3.3 Global Weight Control Medication Revenue by Companies
3.4 Top 3 and Top 5 Weight Control Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Weight Control Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Weight Control Medication Players in Global Market
3.6.1 List of Global Tier 1 Weight Control Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Weight Control Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Weight Control Medication Market Size Markets, 2022 & 2029
4.1.2 Capsule Type
4.1.3 Flaky Type
4.2 By Type – Global Weight Control Medication Revenue & Forecasts
4.2.1 By Type – Global Weight Control Medication Revenue, 2018-2023
4.2.2 By Type – Global Weight Control Medication Revenue, 2024-2029
4.2.3 By Type – Global Weight Control Medication Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Weight Control Medication Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Aldult
5.2 By Application – Global Weight Control Medication Revenue & Forecasts
5.2.1 By Application – Global Weight Control Medication Revenue, 2018-2023
5.2.2 By Application – Global Weight Control Medication Revenue, 2024-2029
5.2.3 By Application – Global Weight Control Medication Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Weight Control Medication Market Size, 2022 & 2029
6.2 By Region – Global Weight Control Medication Revenue & Forecasts
6.2.1 By Region – Global Weight Control Medication Revenue, 2018-2023
6.2.2 By Region – Global Weight Control Medication Revenue, 2024-2029
6.2.3 By Region – Global Weight Control Medication Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Weight Control Medication Revenue, 2018-2029
6.3.2 US Weight Control Medication Market Size, 2018-2029
6.3.3 Canada Weight Control Medication Market Size, 2018-2029
6.3.4 Mexico Weight Control Medication Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Weight Control Medication Revenue, 2018-2029
6.4.2 Germany Weight Control Medication Market Size, 2018-2029
6.4.3 France Weight Control Medication Market Size, 2018-2029
6.4.4 U.K. Weight Control Medication Market Size, 2018-2029
6.4.5 Italy Weight Control Medication Market Size, 2018-2029
6.4.6 Russia Weight Control Medication Market Size, 2018-2029
6.4.7 Nordic Countries Weight Control Medication Market Size, 2018-2029
6.4.8 Benelux Weight Control Medication Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Weight Control Medication Revenue, 2018-2029
6.5.2 China Weight Control Medication Market Size, 2018-2029
6.5.3 Japan Weight Control Medication Market Size, 2018-2029
6.5.4 South Korea Weight Control Medication Market Size, 2018-2029
6.5.5 Southeast Asia Weight Control Medication Market Size, 2018-2029
6.5.6 India Weight Control Medication Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Weight Control Medication Revenue, 2018-2029
6.6.2 Brazil Weight Control Medication Market Size, 2018-2029
6.6.3 Argentina Weight Control Medication Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Weight Control Medication Revenue, 2018-2029
6.7.2 Turkey Weight Control Medication Market Size, 2018-2029
6.7.3 Israel Weight Control Medication Market Size, 2018-2029
6.7.4 Saudi Arabia Weight Control Medication Market Size, 2018-2029
6.7.5 UAE Weight Control Medication Market Size, 2018-2029
7 Weight Control Medication Companies Profiles
7.1 Versanis
7.1.1 Versanis Company Summary
7.1.2 Versanis Business Overview
7.1.3 Versanis Weight Control Medication Major Product Offerings
7.1.4 Versanis Weight Control Medication Revenue in Global Market (2018-2023)
7.1.5 Versanis Key News & Latest Developments
7.2 Rivus Pharmaceuticals
7.2.1 Rivus Pharmaceuticals Company Summary
7.2.2 Rivus Pharmaceuticals Business Overview
7.2.3 Rivus Pharmaceuticals Weight Control Medication Major Product Offerings
7.2.4 Rivus Pharmaceuticals Weight Control Medication Revenue in Global Market (2018-2023)
7.2.5 Rivus Pharmaceuticals Key News & Latest Developments
7.3 Spitfire Pharma
7.3.1 Spitfire Pharma Company Summary
7.3.2 Spitfire Pharma Business Overview
7.3.3 Spitfire Pharma Weight Control Medication Major Product Offerings
7.3.4 Spitfire Pharma Weight Control Medication Revenue in Global Market (2018-2023)
7.3.5 Spitfire Pharma Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Weight Control Medication Major Product Offerings
7.4.4 GSK Weight Control Medication Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Altimmune
7.5.1 Altimmune Company Summary
7.5.2 Altimmune Business Overview
7.5.3 Altimmune Weight Control Medication Major Product Offerings
7.5.4 Altimmune Weight Control Medication Revenue in Global Market (2018-2023)
7.5.5 Altimmune Key News & Latest Developments
7.6 Currax Pharmaceuticals
7.6.1 Currax Pharmaceuticals Company Summary
7.6.2 Currax Pharmaceuticals Business Overview
7.6.3 Currax Pharmaceuticals Weight Control Medication Major Product Offerings
7.6.4 Currax Pharmaceuticals Weight Control Medication Revenue in Global Market (2018-2023)
7.6.5 Currax Pharmaceuticals Key News & Latest Developments
7.7 Wanbang Pharmaceutical Technology
7.7.1 Wanbang Pharmaceutical Technology Company Summary
7.7.2 Wanbang Pharmaceutical Technology Business Overview
7.7.3 Wanbang Pharmaceutical Technology Weight Control Medication Major Product Offerings
7.7.4 Wanbang Pharmaceutical Technology Weight Control Medication Revenue in Global Market (2018-2023)
7.7.5 Wanbang Pharmaceutical Technology Key News & Latest Developments
7.8 Highfine Biotech
7.8.1 Highfine Biotech Company Summary
7.8.2 Highfine Biotech Business Overview
7.8.3 Highfine Biotech Weight Control Medication Major Product Offerings
7.8.4 Highfine Biotech Weight Control Medication Revenue in Global Market (2018-2023)
7.8.5 Highfine Biotech Key News & Latest Developments
7.9 Keyuan Pharmaceutical
7.9.1 Keyuan Pharmaceutical Company Summary
7.9.2 Keyuan Pharmaceutical Business Overview
7.9.3 Keyuan Pharmaceutical Weight Control Medication Major Product Offerings
7.9.4 Keyuan Pharmaceutical Weight Control Medication Revenue in Global Market (2018-2023)
7.9.5 Keyuan Pharmaceutical Key News & Latest Developments
7.10 BrightGene Bio-Medical Technology
7.10.1 BrightGene Bio-Medical Technology Company Summary
7.10.2 BrightGene Bio-Medical Technology Business Overview
7.10.3 BrightGene Bio-Medical Technology Weight Control Medication Major Product Offerings
7.10.4 BrightGene Bio-Medical Technology Weight Control Medication Revenue in Global Market (2018-2023)
7.10.5 BrightGene Bio-Medical Technology Key News & Latest Developments
7.11 Sinopep-Allsino Bio Pharmaceutical
7.11.1 Sinopep-Allsino Bio Pharmaceutical Company Summary
7.11.2 Sinopep-Allsino Bio Pharmaceutical Business Overview
7.11.3 Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Major Product Offerings
7.11.4 Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Revenue in Global Market (2018-2023)
7.11.5 Sinopep-Allsino Bio Pharmaceutical Key News & Latest Developments
7.12 Dezhan Healthcare
7.12.1 Dezhan Healthcare Company Summary
7.12.2 Dezhan Healthcare Business Overview
7.12.3 Dezhan Healthcare Weight Control Medication Major Product Offerings
7.12.4 Dezhan Healthcare Weight Control Medication Revenue in Global Market (2018-2023)
7.12.5 Dezhan Healthcare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Weight Control Medication Market Opportunities & Trends in Global Market
Table 2. Weight Control Medication Market Drivers in Global Market
Table 3. Weight Control Medication Market Restraints in Global Market
Table 4. Key Players of Weight Control Medication in Global Market
Table 5. Top Weight Control Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Weight Control Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Weight Control Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Weight Control Medication Product Type
Table 9. List of Global Tier 1 Weight Control Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Weight Control Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Weight Control Medication Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Weight Control Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Weight Control Medication Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Weight Control Medication Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Weight Control Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Weight Control Medication Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Weight Control Medication Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Weight Control Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Weight Control Medication Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Weight Control Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Weight Control Medication Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Weight Control Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Weight Control Medication Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Weight Control Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Weight Control Medication Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Weight Control Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Weight Control Medication Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Weight Control Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Weight Control Medication Revenue, (US$, Mn), 2024-2029
Table 30. Versanis Company Summary
Table 31. Versanis Weight Control Medication Product Offerings
Table 32. Versanis Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 33. Versanis Key News & Latest Developments
Table 34. Rivus Pharmaceuticals Company Summary
Table 35. Rivus Pharmaceuticals Weight Control Medication Product Offerings
Table 36. Rivus Pharmaceuticals Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 37. Rivus Pharmaceuticals Key News & Latest Developments
Table 38. Spitfire Pharma Company Summary
Table 39. Spitfire Pharma Weight Control Medication Product Offerings
Table 40. Spitfire Pharma Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 41. Spitfire Pharma Key News & Latest Developments
Table 42. GSK Company Summary
Table 43. GSK Weight Control Medication Product Offerings
Table 44. GSK Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 45. GSK Key News & Latest Developments
Table 46. Altimmune Company Summary
Table 47. Altimmune Weight Control Medication Product Offerings
Table 48. Altimmune Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Altimmune Key News & Latest Developments
Table 50. Currax Pharmaceuticals Company Summary
Table 51. Currax Pharmaceuticals Weight Control Medication Product Offerings
Table 52. Currax Pharmaceuticals Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 53. Currax Pharmaceuticals Key News & Latest Developments
Table 54. Wanbang Pharmaceutical Technology Company Summary
Table 55. Wanbang Pharmaceutical Technology Weight Control Medication Product Offerings
Table 56. Wanbang Pharmaceutical Technology Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 57. Wanbang Pharmaceutical Technology Key News & Latest Developments
Table 58. Highfine Biotech Company Summary
Table 59. Highfine Biotech Weight Control Medication Product Offerings
Table 60. Highfine Biotech Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Highfine Biotech Key News & Latest Developments
Table 62. Keyuan Pharmaceutical Company Summary
Table 63. Keyuan Pharmaceutical Weight Control Medication Product Offerings
Table 64. Keyuan Pharmaceutical Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 65. Keyuan Pharmaceutical Key News & Latest Developments
Table 66. BrightGene Bio-Medical Technology Company Summary
Table 67. BrightGene Bio-Medical Technology Weight Control Medication Product Offerings
Table 68. BrightGene Bio-Medical Technology Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 69. BrightGene Bio-Medical Technology Key News & Latest Developments
Table 70. Sinopep-Allsino Bio Pharmaceutical Company Summary
Table 71. Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Product Offerings
Table 72. Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 73. Sinopep-Allsino Bio Pharmaceutical Key News & Latest Developments
Table 74. Dezhan Healthcare Company Summary
Table 75. Dezhan Healthcare Weight Control Medication Product Offerings
Table 76. Dezhan Healthcare Weight Control Medication Revenue (US$, Mn) & (2018-2023)
Table 77. Dezhan Healthcare Key News & Latest Developments
List of Figures
Figure 1. Weight Control Medication Segment by Type in 2022
Figure 2. Weight Control Medication Segment by Application in 2022
Figure 3. Global Weight Control Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Weight Control Medication Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Weight Control Medication Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Weight Control Medication Revenue in 2022
Figure 8. By Type - Global Weight Control Medication Revenue Market Share, 2018-2029
Figure 9. By Application - Global Weight Control Medication Revenue Market Share, 2018-2029
Figure 10. By Type - Global Weight Control Medication Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Weight Control Medication Revenue Market Share, 2018-2029
Figure 12. By Application - Global Weight Control Medication Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Weight Control Medication Revenue Market Share, 2018-2029
Figure 14. By Region - Global Weight Control Medication Revenue Market Share, 2018-2029
Figure 15. By Country - North America Weight Control Medication Revenue Market Share, 2018-2029
Figure 16. US Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Weight Control Medication Revenue Market Share, 2018-2029
Figure 20. Germany Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 21. France Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Weight Control Medication Revenue Market Share, 2018-2029
Figure 28. China Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 32. India Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Weight Control Medication Revenue Market Share, 2018-2029
Figure 34. Brazil Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Weight Control Medication Revenue Market Share, 2018-2029
Figure 37. Turkey Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Weight Control Medication Revenue, (US$, Mn), 2018-2029
Figure 41. Versanis Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Rivus Pharmaceuticals Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Spitfire Pharma Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GSK Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Altimmune Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Currax Pharmaceuticals Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Wanbang Pharmaceutical Technology Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Highfine Biotech Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Keyuan Pharmaceutical Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. BrightGene Bio-Medical Technology Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Dezhan Healthcare Weight Control Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 片頭痛治療薬のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、アセトアミノフェン、トリプタン、その他
  • 処方片頭痛薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
  • GLP-1減量薬のグローバル市場展望 2023年-2029年：注射剤、経口剤
  • 減量用胃内バルーンのグローバル市場展望 2023年-2029年：エアレーション、水充填
  • 減量用胃ポンプのグローバル市場展望 2023年-2029年：過食症、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14516 )"体重管理薬のグローバル市場展望 2023年-2029年：カプセル型、フレーク型" (英文：Weight Control Medication Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。